Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
Year: 2024
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Institutions: Sun Yat-sen University, Sun Yat-sen Memorial Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, The First Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital of Wenzhou Medical University, Peking University Cancer Hospital, Zhejiang University, Junshi Biosciences (China)
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396509244